21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
32.50.Z - Production of medical devices, instruments, and products, including dental products
46.46.Z - Wholesale trade of pharmaceutical and medical products
46.90.Z - Non-specialized wholesale trade
59.20.Z - Sound recording and music publishing activities
63.99.Z - Services related to computing infrastructure, data processing, website management (hosting), and other information services
72.19.Z - Scientific research and development activities
74.10.Z - Specialized design activities
74.90.Z - Other professional, scientific and technical activities, not elsewhere classified
82.91.Z - Activities of collection agencies and credit bureaus
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 45,2 | 41 | 34,5 | -15,9 |
EBITDA | 69,8 | 67,1 | 58 | -13,5 |
Short time liabilities | 81,4 | 87,3 | 144,1 | 65 |
Equity capital | 125,7 | 131,6 | 152,6 | 15,9 |
Operating profit (EBIT) | 52,4 | 48,9 | 41,3 | -15,5 |
Assets | 306,4 | 303,6 | 340,7 | 12,2 |
Net profit (loss) | 38 | 40,6 | 31,1 | -23,5 |
Cash | 2,1 | 14,3 | 8,3 | -42,2 |
Net income from sale | 267,9 | 288,7 | 317,9 | 10,1 |
Liabilities and provisions for liabilities | 180,7 | 172 | 188,1 | 9,4 |
Working assets | 182,4 | 204,9 | 199,4 | -2,7 |
Depreciation | 17,4 | 18,2 | 16,7 | -8,2 |
% | % | % | p.p. | |
Profitability of capital | 30,2 | 30,9 | 20,4 | -10,5 |
Equity capital to total assets | 41 | 43,4 | 44,8 | 1,4 |
Gross profit margin | 16,9 | 14,2 | 10,8 | -3,4 |
EBITDA Margin | 26 | 23,2 | 18,3 | -4,9 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 111 | 110 | 166 | 56 |
Current financial liquidity indicator | 2.0136020183563232 | 2.166665554046631 | 1.3285002708435059 | -0,9 |
Net dept to EBITDA | 1.6441198587417603 | 1.3145993947982788 | 1.6860127449035645 | 0,4 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane